Answers are grounded in this paper and cite their sources.
Identifying subependymal lesions (SELs) at risk of subependymal giant cell astrocytoma (SEGA) development is important in patients with tuberous sclerosis complex (TSC). SELs are currently defined by size and growth, while definite SEGA diagnosis requires histopathologic evaluation. The aim of this study was to (1) analyze baseline volume and growth patterns of SELs, (2) assess methods to identify potentially hazardous lesions requiring close monitoring or treatment, and (3) evaluate determinants of abnormally growing SELs suspected of being SEGAs.
No takes yet. Share an insight, caveat, or question.
Stevering et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: